Jean-Paul Soulillou mostly deals with Immunology, Transplantation, Kidney transplantation, Immunosuppression and Internal medicine. His studies link Cytotoxic T cell with Immunology. His Transplantation research incorporates themes from In vitro, Kidney, Kidney disease and Renal function.
His study in Kidney transplantation is interdisciplinary in nature, drawing from both Intensive care medicine, Microarray, Peripheral blood mononuclear cell, Gene signature and Biomarker. His study explores the link between Immunosuppression and topics such as Gastroenterology that cross with problems in Randomized controlled trial, Basiliximab, Randomization and Tolerability. Interleukin 6 and Leukemia inhibitory factor is closely connected to Endocrinology in his research, which is encompassed under the umbrella topic of Internal medicine.
His primary scientific interests are in Immunology, Transplantation, Antibody, Kidney transplantation and Kidney. He regularly ties together related areas like Cytotoxic T cell in his Immunology studies. Jean-Paul Soulillou has included themes like Immunosuppression and Kidney disease in his Transplantation study.
His research in Antibody focuses on subjects like Molecular biology, which are connected to Endothelial stem cell and Cytokine. His research in Kidney transplantation intersects with topics in Biomarker, Immune tolerance, Bioinformatics and Intensive care medicine. The various areas that Jean-Paul Soulillou examines in his Kidney study include Urinary system and Pathology.
His main research concerns Immunology, Transplantation, Antibody, Kidney transplantation and Immunosuppression. Jean-Paul Soulillou has researched Immunology in several fields, including Phenotype and Kidney. His Transplantation study results in a more complete grasp of Internal medicine.
His Antibody study incorporates themes from Molecular biology and Human leukocyte antigen, Antigen. His research in Kidney transplantation intersects with topics in Biomarker, Isoantibodies, Bioinformatics and Gene expression profiling. His work deals with themes such as Transplant rejection and FOXP3, which intersect with Immunosuppression.
His primary areas of investigation include Immunology, Transplantation, T cell, Kidney transplantation and Antibody. Jean-Paul Soulillou has included themes like Peripheral blood mononuclear cell and Xenotransplantation in his Immunology study. His research investigates the link between Transplantation and topics such as Immunosuppression that cross with problems in Glucocorticoid-Induced TNFR-Related Protein.
His T cell study combines topics from a wide range of disciplines, such as Humanized mouse, Systemic inflammation and Ulcerative colitis. Jean-Paul Soulillou works mostly in the field of Kidney transplantation, limiting it down to concerns involving Biomarker and, occasionally, Personalized medicine, Gene signature, Meta-analysis, Immune tolerance and Transcriptome. His Antibody research includes themes of Pharmacokinetics, Pharmacodynamics, Antagonist and Potency.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients
Björn Nashan;Richard Moore;Peter Amlot;Albrecht-Georg Schmidt.
The Lancet (1997)
Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens
Jacques Dantal;Maryvonne Hourmant;Diego Cantarovich;Magali Giral.
The Lancet (1998)
Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans
Pervinder Sagoo;Esperanza Perucha;Birgit Sawitzki;Stefan Tomiuk.
Journal of Clinical Investigation (2010)
A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells.
Dominique Chabannes;Marcelo Hill;Emmanuel Merieau;Julien Rossignol.
Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance
Sophie Brouard;Elaine Mansfield;Christophe Braud;Li Li.
Proceedings of the National Academy of Sciences of the United States of America (2007)
Frequency and Clinical Implications of Development of Donor-Specific and Non–Donor-Specific HLA Antibodies after Kidney Transplantation
Maryvonne Hourmant;Anne Cesbron-Gautier;Paul I. Terasaki;Kazuo Mizutani.
Journal of The American Society of Nephrology (2005)
Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance.
Stéphanie Louis;Cécile Braudeau;Magali Giral;Alexandre Dupont.
Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation.
Agnes Debout;Yohann Foucher;Katy Trébern-Launay;Christophe Legendre;Christophe Legendre.
Kidney International (2015)
Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial
M Behrend;J Grinyo;Y Vanrenterghem;J Rodicio.
Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys
Magali Giral-Classe;Maryvonne Hourmant;Diego Cantarovich;Jacques Dantal.
Kidney International (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: